Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...

The new bat coronavirus was discovered in Brazil and has a spike protein that is 72% similar to the one found in the Middle ...

Scientists have found a new coronavirus in bats in Brazil with strong similarities to Middle East respiratory syndrome (MERS) ...

The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

Scientists in Brazil have discovered a new coronavirus in bats similar to the deadly MERS virus While its risk to humans ...

Scientists at Cornell University have developed a new type of vaccine that may provide stronger and longer-lasting protection ...

Misinformation about vaccines has swirled online since US President Donald Trump appointed Robert F. Kennedy Jr. – who has ...

Researchers have identified a new coronavirus in bats in Brazil, raising concerns about its potential risks to humans. The ...

Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAb in their systems.